SCHEMBL28738065

SCHEMBL28738065

CS(=O)(=O)c1cccc(OC[C@@H](O)COC(N)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.52
KDM4E B2RXH2 2/20 0.51
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PRMT5 O14744 3/20 0.47
WDR77 Q9BQA1 2/20 0.47
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HIF1A Q16665 1/20 0.42
NR1H2 P55055 2/20 0.40
F2 P00734 1/20 0.40
KAT6A Q92794 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
NR1H3 Q13133 1/20 0.39
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737943 1.00 CYP1A2 (0.52) CYP1A2KDM4ELMNASMN1; SMN2PRMT5
SCHEMBL28737942 1.00 CYP1A2 (0.52) CYP1A2KDM4ELMNASMN1; SMN2PRMT5
SCHEMBL28737753 0.88 CYP1A2 (0.50) CYP1A2KDM4ELMNASMN1; SMN2TSHR
SCHEMBL28737751 0.88 CYP1A2 (0.50) CYP1A2KDM4ELMNASMN1; SMN2TSHR
SCHEMBL28470107 0.86 CYP1A2 (0.49) CYP1A2KDM4ELMNASMN1; SMN2TSHR
SCHEMBL28470108 0.86 CYP1A2 (0.49) CYP1A2KDM4ELMNASMN1; SMN2TSHR
SCHEMBL28737765 0.83 CYP1A2 (0.48) CYP1A2KDM4ELMNASMN1; SMN2MAPK1
SCHEMBL28737763 0.83 CYP1A2 (0.48) CYP1A2KDM4ELMNASMN1; SMN2MAPK1
SCHEMBL19692903 0.79 LMNA (0.54) LMNAPRMT5WDR77TSHRMAPK1
SCHEMBL29650185 0.79 LMNA (0.54) LMNAPRMT5WDR77TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed